Gene: CACNG8
Official Full Name: calcium voltage-gated channel auxiliary subunit gamma 8provided by HGNC
Gene Summary: The protein encoded by this gene is a type I transmembrane AMPA receptor regulatory protein (TARP). TARPs regulate both trafficking and channel gating of the AMPA receptors. This gene is part of a functionally diverse eight-member protein subfamily of the PMP-22/EMP/MP20 family and is located in a cluster with two family members, a type II TARP and a calcium channel gamma subunit. The mRNA for this gene is believed to initiate translation from a non-AUG (CUG) start codon. [provided by RefSeq, Dec 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19119 | CACNG8 Knockout cell line (HEK293) | Human | CACNG8 | 1:3~1:6 | Negative | Online Inquiry |
KO19120 | CACNG8 Knockout cell line (A549) | Human | CACNG8 | 1:3~1:4 | Negative | Online Inquiry |
CACNG8 Gene Knockout Cell Lines are specialized human cell models in which the CACNG8 gene has been systematically disrupted, resulting in a loss of function of the encoded protein. This gene is part of the voltage-gated calcium channel complex, which plays a critical role in calcium ion signaling pathways essential for various physiological processes, including synaptic transmission and muscle contraction. By utilizing these knockout cell lines, researchers can delve into the specific roles and implications of the CACNG8 protein in both normal and pathological states.
The key function of the CACNG8 Gene Knockout Cell Lines lies in their ability to elucidate the biological mechanisms underlying calcium signaling, which are vital in neurobiology, cardiology, and other fields of biomedical research. These cell lines serve as a powerful tool for studying the pathophysiology of conditions such as neurodegenerative diseases, cardiovascular disorders, and certain types of cancer, allowing for detailed analyses of cellular responses and alterations in signaling pathways.
Scientifically, the CACNG8 knockout models enable researchers to dissect the functional consequences of impaired calcium signaling and to investigate potential therapeutic targets. The implications of this research extend into clinical settings where understanding the molecular basis of disease can lead to the development of novel drugs and therapeutic strategies.
Compared to alternative cell models, CACNG8 Gene Knockout Cell Lines offer enhanced specificity and relevance to human physiology, reducing the translational gap often observed with traditional animal models. They provide a unique advantage for high-throughput screening and drug discovery by facilitating more accurate modeling of human disease mechanisms.
For researchers and clinicians seeking innovative solutions, the value of these knockout cell lines lies not only in their ability to address complex biological questions but also in their potential to accelerate the development of targeted therapies.
Our company specializes in providing high-quality biological products, and our expertise positions us at the forefront of research support, ensuring that our clients have access to the most reliable and effective tools to advance their scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.